Octopus Medical Technologies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-10-2024
- Paid Up Capital ₹ 0.10 M
as on 23-10-2024
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -27.05%
(FY 2023)
- Profit -42.40%
(FY 2023)
- Ebitda -38.22%
(FY 2023)
- Net Worth 23.04%
(FY 2023)
- Total Assets 18.96%
(FY 2023)
About Octopus Medical Technologies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bhushita Pathik and Nivedita Narkhede serve as directors at the Company.
- CIN/LLPIN
U33110GJ2013PTC076734
- Company No.
076734
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Sep 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Octopus Medical Technologies Private Limited offer?
Octopus Medical Technologies Private Limited offers a wide range of products and services, including Diagnostic Medical Imaging Equipment, Doppler Machine, Pharmaceutical Machinery & Equipment, Pharmaceutical Machines, Surgical & ICU Equipments, Ventilator, Endoscopy & Laparoscopy instruments, Surgical Equipments, Industrial Mixers & Homogenizers, Powder Mixers.
Who are the key members and board of directors at Octopus Medical Technologies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhushita Pathik  | Director | 06-Sep-2013 | Current |
| Nivedita Narkhede | Director | 10-Jan-2017 | Current |
Financial Performance of Octopus Medical Technologies.
Octopus Medical Technologies Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 27.05% decrease. The company also saw a substantial fall in profitability, with a 42.4% decrease in profit. The company's net worth Soared by an impressive increase of 23.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Octopus Medical Technologies?
In 2022, Octopus Medical Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Octopus Medical Technologies?
Unlock and access historical data on people associated with Octopus Medical Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Octopus Medical Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Octopus Medical Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
